Showing results (41-50 of 446) with videos related to
Sort By:
Pageof 45
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 1, 1996
A phase I investigation of the sequential use of methotrexate and paclitaxel with and without G-CSF for the treatment of solid tumorsM H Huber, J S Lee, R A Newman, et al.The New England Journal of Medicine|May 25, 1995
Suppression of retinoic acid receptor-beta in premalignant oral lesions and its up-regulation by isotretinoinR Lotan, X C Xu, S M Lippman, et al.International Journal of Cancer|August 19, 1992
Micronuclei in bronchial biopsy specimens from heavy smokers: characterization of an intermediate marker of lung carcinogenesisS E Benner, S M Lippman, M J Wargovich, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 1, 1997
Phase I trial of alpha-tocopherol effects on 13-cis-retinoic acid toxicityI W Dimery, W K Hong, J J Lee, et al.American Journal of Clinical Oncology|August 1, 1996
A phase II study of ifosfamide in recurrent squamous cell carcinoma of the head and neckM H Huber, S M Lippman, S E Benner, et al.Cancer Research|May 1, 1992
Determination of biomarkers for intermediate end points in chemoprevention trialsJ S Lee, S M Lippman, W K Hong, et al.Cancer Research|December 1, 1995
Anti-retinoic acid (RA) antibody binding to human premalignant oral lesions, which occurs less frequently than binding to normal tissue, increases after 13-cis-RA treatment in vivo and is related to RA receptor beta expressionX C Xu, M H Zile, S M Lippman, et al.Journal of the National Cancer Institute|January 6, 1993
Regression of oral leukoplakia with alpha-tocopherol: a community clinical oncology program chemoprevention studyS E Benner, R J Winn, S M Lippman, et al.The Journal of Nutrition|March 18, 2000
Advances in the development of retinoids as chemopreventive agentsS M Lippman, R LotanCancer Research|August 28, 2001
Lipoxygenase modulation to reverse carcinogenesisI Shureiqi, S M LippmanPageof 45